Across TCGA pan-cancer cohorts, RSU1P3 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RSU1P3’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where RSU1P3 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RSU1P3 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

BRCA and THCA are the cancer types where RSU1P3 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RSU1P3 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	All	+0.126	.045	2	view →
THCA	All	All	−0.021	.025	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: RSU1P3 RNA expression & survival · all RSU1P3 data types